These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 28398951)

  • 41. Assessment of transurethral resection of the bladder specimens with pT1 high-grade urothelial carcinoma for the predictor features of muscularis propria invasion on radical cystectomy specimens.
    Kir GG; Girgin RBB; Soylemez Söylemez TT; Melemez MKK; Topal CSS; Turan T; Caskurlu Çaşkurlu T; Yıldırım AA
    Ann Diagn Pathol; 2018 Dec; 37():25-29. PubMed ID: 30236545
    [No Abstract]   [Full Text] [Related]  

  • 42. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients.
    Orsola A; Trias I; Raventós CX; Español I; Cecchini L; Búcar S; Salinas D; Orsola I
    Eur Urol; 2005 Aug; 48(2):231-8; discussion 238. PubMed ID: 15963635
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Substaging of pT1 Urothelial Bladder Carcinoma Predicts Tumor Progression and Overall Survival.
    Grobet-Jeandin E; Wirth GJ; Benamran D; Dupont A; Tille JC; Iselin CE
    Urol Int; 2022; 106(2):130-137. PubMed ID: 33965961
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of T1 substaging on oncological outcomes in patients with non-muscle-invasive bladder urothelial carcinoma: a systematic literature review and meta-analysis.
    Kardoust Parizi M; Enikeev D; Glybochko PV; Seebacher V; Janisch F; Fajkovic H; Chłosta PL; Shariat SF
    World J Urol; 2020 Jun; 38(6):1437-1449. PubMed ID: 31493109
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transurethral resection specimens of the bladder: outcome of invasive urothelial cancer involving muscle bundles indeterminate between muscularis mucosae and muscularis propria.
    Miyamoto H; Epstein JI
    Urology; 2010 Sep; 76(3):600-2. PubMed ID: 20394971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.
    Rouprêt M; Seisen T; Compérat E; Larré S; Mazerolles C; Gobet F; Fetissof F; Fromont G; Safsaf A; d'Arcier BF; Celhay O; Validire P; Rozet F; Irani J; Soulié M; Pfister C;
    J Urol; 2013 Jun; 189(6):2069-76. PubMed ID: 23201497
    [TBL] [Abstract][Full Text] [Related]  

  • 48. pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder.
    Tilki D; Svatek RS; Karakiewicz PI; Novara G; Seitz M; Sonpavde G; Gupta A; Kassouf W; Fradet Y; Ficarra V; Skinner E; Lotan Y; Sagalowsky AI; Stief CG; Reich O; Shariat SF
    J Urol; 2010 Aug; 184(2):470-4. PubMed ID: 20620401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The value of tumour spread, grading and growth pattern as morphological predictive parameters in bladder carcinoma. A critical revision of the 1987 TNM classification.
    Angulo JC; Lopez JI; Flores N; Toledo JD
    J Cancer Res Clin Oncol; 1993; 119(10):578-93. PubMed ID: 8335677
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple adverse histological features increase the odds of under staging T1 bladder cancer.
    Weizer AZ; Wasco MJ; Wang R; Daignault S; Lee CT; Shah RB
    J Urol; 2009 Jul; 182(1):59-65; discussion 65. PubMed ID: 19447443
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathological staging of muscle invasive bladder cancer. Is substaging of pT2 tumors really necessary?
    Tokgoz H; Turkolmez K; Resorlu B; Kose K; Tulunay O; Beduk Y
    Int Braz J Urol; 2007; 33(6):777-83; discussion 783-4. PubMed ID: 18199345
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation between biopsy and radical cystectomy in assessing grade and depth of invasion in bladder urothelial carcinoma.
    Chang BS; Kim HL; Yang XJ; Steinberg GD
    Urology; 2001 Jun; 57(6):1063-6; discussion 1066-7. PubMed ID: 11377305
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of Inter-Observer Variability and Quantification of Muscularis Propria in the Pathological Staging of Bladder Cancer.
    Giunchi F; Panzacchi R; Capizzi E; Schiavina R; Brunocilla E; Martorana G; D'Errico A; Fiorentino M
    Clin Genitourin Cancer; 2016 Aug; 14(4):e307-12. PubMed ID: 26874973
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of high-risk non-muscle invasive bladder cancer.
    Brausi M; Olaru V
    Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Analysis of 34 cases of infiltrating carcinoma of the bladder treated exclusively with partial cystectomy (part 1)].
    Escudero Barrilero A; Fernández Fernández E; Jiménez Cidre M; Maganto Pavón E; Mayayo Dehesa T; Rodríguez Rodríguez R; Galvis San Juan F; Burgos Revilla FJ
    Arch Esp Urol; 1996 May; 49(4):349-64. PubMed ID: 8754191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
    Chang WC; Chang YH; Pan CC
    Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer-evaluation of a large hospital-based single-centre series.
    Bertz S; Denzinger S; Otto W; Wieland WF; Stoehr R; Hofstaedter F; Hartmann A
    Histopathology; 2011 Oct; 59(4):722-32. PubMed ID: 22014053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic value of micrometric substaging in pT1 bladder cancer patients treated with en-bloc transurethral resection.
    Yanagisawa T; Sato S; Hayashida Y; Okada Y; Matsukawa A; Iwatani K; Shimoda M; Takahashi H; Kimura T; Shariat SF; Miki J
    Histopathology; 2024 Jul; 85(1):92-103. PubMed ID: 38477374
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of a second transurethral resection on the staging of T1 bladder cancer.
    Dalbagni G; Herr HW; Reuter VE
    Urology; 2002 Nov; 60(5):822-4; discussion 824-5. PubMed ID: 12429307
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancer.
    Hermann GG; Horn T; Steven K
    J Urol; 1998 Jan; 159(1):91-4. PubMed ID: 9400444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.